Skip to main content
Caplight Logo









Korio, Inc.

Korio, Inc.

Private
Doylestown, PennsylvaniaHealthcare & Life Scienceshttps://www.korioclinical.com/

Last Round

Series A

Sep 10, 2024

Est. Valuation

$17M

Total Funding Raised

$12.3M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Korio, Inc. is a healthtech company that provides a technology-first Randomization & Trial Supply Management (RTSM) platform for clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Pharma Supply Chain, Compliance, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

randomization and trial supply managementRTSMinteractive response technologyIRTclinical trial softwareclinical supply chaineClinicalclinical trial managementmid-study migrationtrial protocol changesclinical trial logisticsvertical SaaSaudit-readinessCRO softwarepharma tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Korio, Inc. Comparables

Compare Korio, Inc. with similar companies based on industry and business-model similarity.

Korio, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
4G Clinical
87%
Suvoda
84%
Medrio
81%

Korio, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 10, 2024
SeedOct 10, 2023

Key People

Founding team and executive leadership

Chuck Harris

Founder, COO

Founding Team

Ryan Keane

Founder, CEO

Founding Team

Korio, Inc. Investors

Notable investors and investment history

Korio, Inc. investors
InvestorRounds
BIP VenturesSeries A
Boston Millennia PartnersSeries A, Seed
Excelerate Health VenturesSeries A, Seed
Boston Millennia PartnersSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 62% MoM.

  • Apr 8, 2025

    Jonathan Andrus joins the Board of Directors.

Korio, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Korio, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Korio, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersDoylestown, Pennsylvania
Employee Range36
Year Founded2021
Last FundingSep 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?